These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16536088)

  • 41. The role of DNA methylation: a challenge for the DOHaD paradigm in going beyond the historical debate.
    Ngo S; Sheppard A
    J Dev Orig Health Dis; 2015 Feb; 6(1):2-4. PubMed ID: 25308082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
    Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
    FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting aberrant chromatin structure in colorectal carcinomas.
    Konishi K; Issa JP
    Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Between genotype and phenotype.
    Nat Genet; 2006 Dec; 38(12):1355. PubMed ID: 17133216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation.
    Zilberman D; Cao X; Jacobsen SE
    Science; 2003 Jan; 299(5607):716-9. PubMed ID: 12522258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes.
    Shiraishi M; Sekiguchi A; Terry MJ; Oates AJ; Miyamoto Y; Chuu YH; Munakata M; Sekiya T
    Oncogene; 2002 May; 21(23):3804-13. PubMed ID: 12032849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.
    Soozangar N; Sadeghi MR; Jeddi F; Somi MH; Shirmohamadi M; Samadi N
    J Cell Physiol; 2018 May; 233(5):3968-3981. PubMed ID: 28888056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.
    Saha A; Jha HC; Upadhyay SK; Robertson ES
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5199-207. PubMed ID: 26324942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In situ bisulfite modification of membrane-immobilized DNA for multiple methylation analysis.
    Wang Y; Zheng W; Luo J; Zhang D; Zuhong L
    Anal Biochem; 2006 Dec; 359(2):183-8. PubMed ID: 17069744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular biology. Genetic events that shape the cancer epigenome.
    Ryan RJ; Bernstein BE
    Science; 2012 Jun; 336(6088):1513-4. PubMed ID: 22723401
    [No Abstract]   [Full Text] [Related]  

  • 54. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
    Court F; Arnaud P
    Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.
    Schlesinger Y; Straussman R; Keshet I; Farkash S; Hecht M; Zimmerman J; Eden E; Yakhini Z; Ben-Shushan E; Reubinoff BE; Bergman Y; Simon I; Cedar H
    Nat Genet; 2007 Feb; 39(2):232-6. PubMed ID: 17200670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigenetics and miRNAs in human cancer.
    Fabbri M; Calin GA
    Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer.
    Baylin SB; Esteller M; Rountree MR; Bachman KE; Schuebel K; Herman JG
    Hum Mol Genet; 2001 Apr; 10(7):687-92. PubMed ID: 11257100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetics in gastroenterological cancer and prospects for translational research.
    Suzuki H; Toyota M; Shinomura Y; Imai K
    Nihon Shokakibyo Gakkai Zasshi; 2007 Sep; 104(9):1319-28. PubMed ID: 17827902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.